Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Hold Reckitt Benckiser Group (RKT) by Deutsche Bank
- Outperform Travis Perkins (TPK) by RBC Capital
- Neutral Cranswick (CWK) by Exane
- Underperform Bytes Technology Group (BYIT) by Exane
- Neutral Balfour Beatty (BBY) by Exane
- Outperform Johnson Service Group (JSG) by Exane
- Neutral Genus (GNS) by Exane
- Outperform Computacenter (CCC) by Exane
- Outperform International Workplace Group (IWG) by Exane
- Underperform Greggs (GRG) by Exane
- Outperform Diploma (DPLM) by Exane
- Neutral Kier Group (KIE) by Exane
- Neutral Morgan Sindall Group (MGNS) by Exane
- Neutral Pets at Home Group (PETS) by Exane
- Neutral Mitie Group (MTO) by Exane
- Outperform Savills (SVS) by Exane
- Outperform Mony Group (MONY) by Exane
- Neutral SSP Group (SSPG) by UBS
- Buy Mondi (MNDI) by Citi
- Buy Filtronic (FTC) by Berenberg
Allergy Therapeutics (AGY) Share Price
Health Care Sector
NOTE: This is based on 23 open tips for Allergy Therapeutics (AGY)
| Latest Bid : 9.50p | Latest Ask : 10.50p |
| High Today : 10.60p | Low Today : 9.50p |
| This Years High : 12.10p | This Years Low : 6.60p |
| Volume : 52,244 | MKT Cap : £500.43M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Allergy Therapeutics (AGY) Overview
We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments. We believe that transformational outcomes for patients are achieved by directly treating the cause, rather than just managing symptoms. Our vaccines are aluminium free. Driving convenience; our ultra-short course treatments make life easier and increase adherence.Allergy Therapeutics (AGY) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 9.50p | Latest Ask : 10.50p |
| High Today : 10.60p | Low Today : 9.50p |
| This Years High : 12.10p | This Years Low : 6.60p |
| Volume : 52,244 | MKT Cap : £500.43M |
Allergy Therapeutics Overview
We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments. We believe that transformational outcomes for patients are achieved by directly treating the cause, rather than just managing symptoms. Our vaccines are aluminium free. Driving convenience; our ultra-short course treatments make life easier and increase adherence.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.